Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/12/2005WO2004106497A3 Imageable animal model of sars infection
05/12/2005WO2004092386A3 Inducing a t cell response with recombinant pestivirus replicons or recombinant pestivirus replicon-transfected dendritic cells
05/12/2005WO2004087196A3 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent
05/12/2005WO2004078124A3 Methods and compositions involving mda-7
05/12/2005WO2004077942A3 Inducible prostate cancer model
05/12/2005WO2004076631A3 Biologically active native biomatrix composition
05/12/2005WO2004072233A3 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use
05/12/2005WO2004067560A3 Herpes simplex vp16 protein binding polypeptides
05/12/2005WO2004037995A3 Methods for treating viral infection using il-28 and il-29
05/12/2005WO2004035605A3 Glycoprotein synthesis
05/12/2005WO2004027039A3 Protein modification and maintenance molecules
05/12/2005WO2004026899A9 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
05/12/2005WO2004018502A8 Compounds binding to p-selectin
05/12/2005WO2003100075A3 Bsnd nucleic acids and proteins
05/12/2005WO2003085124A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/12/2005WO2003022126A3 Compositions and methods for the therapy and diagnosis of colon cancer
05/12/2005WO2002097031A3 Molecules for diagnostics and therapeutics
05/12/2005WO2002072627A8 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050102717 Crop plant cystatin proteinase inhibitors and methods of use
05/12/2005US20050102715 Disease resistance factors
05/12/2005US20050102711 Expression vector comprising nucleotide sequences coding exogenous polypeptide for use in generation of disease, heat, freeze, herbicide and insect resistant plants
05/12/2005US20050101992 Method of Applying Composition To A Surface
05/12/2005US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
05/12/2005US20050101769 CD40-interacting and TRAF-interacting proteins
05/12/2005US20050101768 Nucleotide sequences coding hematopoietin receptor for use as tool in identifying modulators for treatment of cell proliferative disorders
05/12/2005US20050101767 Bacillus voltage-sensitive ion-selective transport protein for use in dientifying antagonist/agonist for prevention and treatment of cardiovascular disorders
05/12/2005US20050101762 Cyclic peptide for use as tool in transmembrane transport; drug delivery
05/12/2005US20050101557 Immunostimulatory nucleic acid molecules
05/12/2005US20050101554 Methods for treating and preventing infectious disease
05/12/2005US20050101537 Use of exendins and agonists thereof for lowering plasma lipid
05/12/2005US20050101532 Protamine fragment compositions and methods of use
05/12/2005US20050101531 Use of recombinant gelatin-like proteins as plasma expanders and compositions suitable for plasma substitution
05/12/2005US20050101530 Cellular virus receptors and methods of use
05/12/2005US20050101529 Protein modification and maintenance molecules
05/12/2005US20050101018 Viral vector encoding pigment epithelium-derived factor
05/12/2005US20050101016 Recovering autoantibodies/blood protein via adjustment in redox states for use in constructing profile for diagnosing autoimmune disorders
05/12/2005US20050101013 Antisense nucleotide sequences for modulating the expression of signal transducer and activator of transcription (STAT) proteins; cancer and tumor treatment; gene expression inhibition
05/12/2005US20050100999 Nucleic acid encoding receptor type protein kinase
05/12/2005US20050100997 Apoptosis inhibitory protein, gene encoding the protein and cDNA thereof
05/12/2005US20050100991 Albumin fusion proteins
05/12/2005US20050100990 Factor VIII compositions and methods
05/12/2005US20050100989 FSH glycosylation mutant
05/12/2005US20050100986 Compositions and methods for targeting a polypeptide to the central nervous system
05/12/2005US20050100985 Saturation mutagenesis in directed evolution
05/12/2005US20050100983 Using transmembrane protein as tool in identifying modulators for treatment and prevention of allergies, asthma, infection, autoimmune, inflammatory, transplant rejection and cancer
05/12/2005US20050100982 Factor IX: remodeling and glycoconjugation of factor IX
05/12/2005US20050100975 Using pregnancy-associated glycoproteins (PAGs) to detect pregnancy in bovine animal
05/12/2005US20050100973 Using synaptosomal associated protein-25 (SNAP-25) as tool to screen for clostridial toxin protease activity; food safety; detecting food poisoning
05/12/2005US20050100970 Method of affinity separation and ligands for use therein
05/12/2005US20050100966 FHOS-interacting proteins and use thereof
05/12/2005US20050100963 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
05/12/2005US20050100960 Noncovalent sidewall functionalization of carbon nanotubes
05/12/2005US20050100954 Fluorescent proteins from aquatic species
05/12/2005US20050100952 Transgenic mammalian cells for use as bioreactors in expression of heterologous gene sequences
05/12/2005US20050100941 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
05/12/2005US20050100940 Novel FDRG protein and nucleic acid molecules and uses therefor
05/12/2005US20050100931 Using tumor antigen expression profiles before and after exposure to testosterone and/or bicalutamide as diagnostic tool in determining efficacy as antitumor agents
05/12/2005US20050100928 Nucleotide sequences coding signal sequence segments comprising , tumor antigen, viral protein and structural protein sequences for use as tool in prevention, diagnosis and treatment of infection and cell proliferative disorders
05/12/2005US20050100925 MUC17 encoding nucleic acid sequences, polypeptides, antibodies and methods of use thereof
05/12/2005US20050100924 C/EBPalpha gene targeting constructs and uses thereof
05/12/2005US20050100923 Expression vector comprising nucleotide sequences coding survival of motor neuron-interacting protein 1 (SIP1) for use in detection, prevention and treatment of neuromuscular disorders
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100913 RNA interference pathway genes as tools for targeted genetic interference
05/12/2005US20050100912 Nucleotide sequences coding polymerase delta small subunit (POLD2), adipocyte enhancer binding protein 1 (AEBP1) and membrane fusion protein (SNARE) for use in diagnosis, prevention and treatment of osteopenic disorders
05/12/2005US20050100908 PC4 transcriptional coactivators
05/12/2005US20050100906 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1.
05/12/2005US20050100896 Amino acid sequences comprising dombrook antigens for use as diagnostic tool in transfusion medicine; blood typing
05/12/2005US20050100895 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
05/12/2005US20050100890 Viron for use as gene transfer construct; gene therapy and tissue targeted therapy; drug delivery
05/12/2005US20050100886 Nucleotide sequences coding dengu virus non-structural and west nile structural protein for use as tool in generating attenuated west nile viral vaccine
05/12/2005US20050100883 Peptide-based diagnostic reagents for SARS
05/12/2005US20050100591 Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems
05/12/2005US20050100557 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
05/12/2005US20050100556 DNA viral vaccine fusion for use in prevention of viral infections and as a drug delivery tool
05/12/2005US20050100554 Chimeric polypeptides, vectors and cells; test for precancerous cells; human papilloma virus
05/12/2005US20050100553 Method for the production of bacterial toxins
05/12/2005US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment
05/12/2005US20050100547 Also a method for detecting an agent capable of binding TRAF2 binding site of sphingosine kinase by contacting cells with a putative agent and detecting an altered expression phenotype
05/12/2005US20050100541 Ligands, including antibodies, showing reactivity against endocrine cells
05/12/2005US20050100533 Promoting osteodifferentiation by coating a substrate with a solution of a synthetic peptide having -Ile-Ala residues folded in a beta-bend and mimics cell binding by collagen, incorporation into a biocompatible gel, exposure to cells; hard and soft tissue repair; dentistry
05/12/2005CA2551074A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005CA2544708A1 Liver cancer biomarkers
05/12/2005CA2544473A1 A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof
05/12/2005CA2544372A1 A pharmaceutical composition for preventing or treating malignant glioma
05/12/2005CA2544300A1 Dose-dependent promoter originating in humans
05/12/2005CA2544298A1 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
05/12/2005CA2544272A1 Meg1 endosperm-specific promoters and genes
05/12/2005CA2544125A1 Use of ephrins and related molecules to regulate cellular proliferation
05/12/2005CA2543999A1 Monkey npy y4 receptor and method of evaluating compound
05/12/2005CA2543935A1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
05/12/2005CA2543763A1 Bacterial virulence factors and uses thereof
05/12/2005CA2543548A1 Expression system for the b subunit of cholera toxin
05/12/2005CA2543538A1 Hbv variants detection and application
05/12/2005CA2543451A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
05/12/2005CA2543206A1 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations
05/12/2005CA2543127A1 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
05/12/2005CA2542951A1 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
05/12/2005CA2542777A1 Stabilised compositions
1 ... 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 ... 2916